GlaxoSmithKline Pharmaceuticals mutual fund holdings
NSE: GLAXOBSE: 500660Pharmaceuticals & BiotechnologyMid Cap
GlaxoSmithKline Pharmaceuticals Limited · Formerly Glaxo (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1969 on BSE, Dec 2000 on NSE
Last close ₹2,494.30down ₹20.80 (0.83%)BSE ₹2,483.55
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,515.10.
30 Oct: open ₹2,527.60, high ₹2,528.90, low ₹2,479.30
52-week range of traded prices to 30 Oct 2026
₹2,088.10Low, 12 Jun 2026₹3,120.70High, 28 Aug 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹42,255 Cr221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.56
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 18.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.29%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 50.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 56.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,34965.0% delivered
137 mutual funds from 29 fund houses held GlaxoSmithKline Pharmaceuticals at the end of Sep 2026, each fund counted once across its plans: ₹2,756 Cr between them Value held by mutual funds. The market value of every mutual fund's holding of the company at the month's end, added up, as each fund reports it. Value held by mutual funds in the glossary, 5.87% Mutual funds' share of the company. The shares every mutual fund holds at the month's end, added up and divided by the company's shares in issue. Read from the funds' own portfolios, so it can differ from the mutual funds line of the company's quarterly shareholding filing. Mutual funds' share of the company in the glossary of the company's shares.
Mutual funds holding GlaxoSmithKline Pharmaceuticals, Sep 2026
Largest holding first.
How many funds hold the company each month, and what their holdings are worth, from each month's portfolio disclosures
- Funds holding it
- Value held, ₹ crore
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Buying and selling, month by month
How many funds bought for the first time, bought again, added, cut or sold out, against their own previous month.
Funds, by what they did
Largest first-time buy in Sep 2026: quant ELSS Tax Saver Fund; largest buy by a fund that held it before: SBI Quant Fund; largest addition: quant Mid Cap Fund.Largest cut in Sep 2026: Tata India Pharma & Healthcare Fund; largest exit: Taurus Mid Cap Fund.
Shares held by all funds
- Shares heldShares held by all funds. The shares every mutual fund holding the company reports at the month's end, added up. Shares held by all funds in the glossary
Fund by fund, month by month
| Fund | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 SBI Midcap FundSBI Mutual Fund | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 11,80,000−20,000 (−1.7%) | 11,80,000 |
 Kotak Large & Mid Cap FundKotak Mahindra Mutual Fund | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 | 11,00,000 |
 Nippon India Pharma FundNippon India Mutual Fund | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,13,226 | 9,28,841+15,615 (+1.7%) | 10,29,460+1,00,619 (+10.8%) | 10,29,460 |
 quant Mid Cap Fundquant Mutual Fund | – | – | – | – | – | – | – | – | – | 1,00,913Bought again | 7,73,550+6,72,637 (+666.6%) | 8,89,486+1,15,936 (+15.0%) |
| Nippon India Growth Mid Cap FundNippon India Mutual Fund | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 | 5,59,000 |
| SBI Dividend Yield FundSBI Mutual Fund | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 | 4,50,000 |
 Bandhan Large & Mid Cap FundBandhan Mutual Fund | – | – | – | – | – | – | – | – | 2,41,430Bought | 3,14,263+72,833 (+30.2%) | 3,47,860+33,597 (+10.7%) | 3,47,860 |
 Bajaj Finserv Flexi Cap FundBajaj Finserv Mutual Fund | 2,72,080+43,873 (+19.2%) | 2,72,080 | 2,90,080+18,000 (+6.6%) | 3,18,621+28,541 (+9.8%) | 3,35,705+17,084 (+5.4%) | 3,35,705 | 3,35,705 | 3,35,705 | 3,35,705 | 3,35,705 | 3,35,705 | 3,35,705 |
| Bandhan ELSS - Tax Saver FundBandhan Mutual Fund | 2,20,000 | 2,30,000+10,000 (+4.6%) | 2,45,000+15,000 (+6.5%) | 2,55,000+10,000 (+4.1%) | 2,55,000 | 2,55,000 | 2,55,000 | 2,55,000 | 2,75,000+20,000 (+7.8%) | 2,75,000 | 2,75,000 | 2,75,000 |
 Tata Aggressive Hybrid FundTata Mutual Fund | – | – | – | – | – | – | – | – | 3,15,000Bought | 3,15,000 | 2,50,000−65,000 (−20.6%) | 2,50,000 |
 Mahindra Manulife Small Cap FundMahindra Manulife Mutual Fund | 1,82,918 | 1,82,918 | 1,82,918 | 1,82,918 | 1,82,918 | 1,82,918 | 1,82,918 | 73,101−1,09,817 (−60.0%) | 53,158−19,943 (−27.3%) | 1,13,165+60,007 (+112.9%) | 2,00,425+87,260 (+77.1%) | 2,34,751+34,326 (+17.1%) |
| quant ELSS Tax Saver Fundquant Mutual Fund | – | – | – | – | – | – | – | – | – | – | – | 1,75,073Bought |
 Aditya Birla Sun Life MNC FundAditya Birla Sun Life Mutual Fund | 2,60,835 | 2,60,835 | 2,60,835 | 2,60,835 | 2,60,835 | 2,60,835 | 2,60,835 | 2,17,353−43,482 (−16.7%) | 1,89,399−27,954 (−12.9%) | 1,89,399 | 1,89,399 | 1,71,506−17,893 (−9.5%) |
 Helios Mid Cap FundHelios Mutual Fund | 16,129 | 16,129 | 20,689+4,560 (+28.3%) | 20,689 | 20,689 | 20,689 | 20,689 | 20,689 | 97,689+77,000 (+372.2%) | 1,47,714+50,025 (+51.2%) | 1,68,366+20,652 (+14.0%) | 1,68,366 |
| Bajaj Finserv Multi Cap FundBajaj Finserv Mutual Fund | 48,493+10,895 (+29.0%) | 52,275+3,782 (+7.8%) | 52,275 | 74,765+22,490 (+43.0%) | 71,340−3,425 (−4.6%) | 71,340 | 71,340 | 71,340 | 96,829+25,489 (+35.7%) | 1,46,019+49,190 (+50.8%) | 1,51,605+5,586 (+3.8%) | 1,57,304+5,699 (+3.8%) |
Shares held at each month end. Under them, the change on the fund's previous month; a fund that files only weights shows the word. “After a gap” is a fund holding it after a month with no portfolio on record, so when it bought is not known; “Not filed” is one gone across such a gap.